about
Inhibition of regulated cell death by cell-penetrating peptidesDrug Delivery Approaches in Addressing Clinical Pharmacology-Related Issues: Opportunities and ChallengesSynthetic biology and therapeutic strategies for the degenerating brain: Synthetic biology approaches can transform classical cell and gene therapies, to provide new cures for neurodegenerative diseasesNanomedicine in Central Nervous System (CNS) Disorders: A Present and Future ProspectiveThe Role of Muscarinic Receptors in the Pathophysiology of Mood Disorders: A Potential Novel Treatment?Drug delivery strategies to enhance the permeability of the blood-brain barrier for treatment of gliomaDevelopment of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson's Disease and Other Brain Disorders.Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone.In Vivo Amyloid-β Imaging in the APPPS1-21 Transgenic Mouse Model with a (89)Zr-Labeled Monoclonal Antibody.Intranasal administration of elastin-like polypeptide for therapeutic delivery to the central nervous systemNanocapsules with Polyelectrolyte Shell as a Platform for 1,25-dihydroxyvitamin D3 Neuroprotection: Study in Organotypic Hippocampal Slices.The nanomaterial toolkit for neuroengineering.Diffuse intrinsic pontine glioma: time for therapeutic optimism.Heterotopic Mucosal Grafting Enables the Delivery of Therapeutic Neuropeptides Across the Blood Brain Barrier.Harnessing nanomedicine for therapeutic intervention in glioblastoma.Increased antiparkinson efficacy of the combined administration of VEGF- and GDNF-loaded nanospheres in a partial lesion model of Parkinson's disease.Nanoparticulate strategies for the treatment of polyglutamine diseases by halting the protein aggregation process.A novel LRP1-binding peptide L57 that crosses the blood brain barrier.Dynamic and Responsive Growth Factor Delivery from Electrospun and Hydrogel Tissue Engineering Materials.Temporally controlled growth factor delivery from a self-assembling peptide hydrogel and electrospun nanofibre composite scaffold.GLUT1 -mediated venlafaxine-thiamine disulfide system-glucose conjugates with "lock-in" function for central nervous system delivery.The delivery of doxorubicin of multifunctional β-cyclodextrin-modified CdSe/ZnS quantum dots for bioactivity and nano-probing.Diagnosis and Treatment of Neurological and Ischemic Disorders Employing Carbon Nanotube Technology
P2860
Q26751423-E787D679-A05B-4B03-B8C5-727915357033Q26798105-34B84222-1CFB-42CD-9FD9-7489B8E3F130Q26830610-B52C73A2-95FC-4C24-9189-4E20E7B7970BQ28075999-2B0F55EA-1206-4D3F-A9A6-A6D955A3FA5CQ28082434-D17E2624-E50E-4CC2-A332-A10FD5ACFB34Q30413487-F2E2A077-003E-463B-BFB1-DAD8882D5B37Q35877637-78EE780A-9404-4E3A-BC38-8D47323D0BDFQ36082516-E9E82F7B-5E14-426E-89D4-664E03706E75Q36748573-5D510A1A-AF0C-4F53-BE0D-AE4901B4139BQ37248790-F98E33BC-4F76-4B1D-B54A-B59C99AB9727Q37306528-02571D94-B741-4EC4-847D-E344DEFA21DCQ37610362-C9C4888F-6ABB-4195-B10F-9D5D82BD74D6Q38264309-BCD01D6D-216F-4585-B7F9-B8B2832CDCC5Q38836658-34F9AD75-9FD9-411B-8898-0C0CF58B49B6Q38862946-FFDAF1D2-492D-4C0A-8806-1E0FBC1B3E91Q38985632-D1D91A85-1786-4B87-B874-FF00BB19177EQ39112084-7564D224-BBFD-4613-994C-960F12D79573Q45734282-9EB1F963-083E-4658-9786-B7536AD6A465Q47295379-41FF97DD-5514-4F2E-9CEB-3945EDA303C7Q47710864-E3C7B34E-CF8B-43C9-AA50-BC0ADACFC59DQ47730436-FCF09392-3A27-42BC-A955-7066FFF8EF57Q47815694-07C9C919-2DA6-4E32-BEF6-895447ECA55EQ59128922-729D2B05-540D-47AA-962D-1BC44C16BF24
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Novel central nervous system drug delivery systems.
@ast
Novel central nervous system drug delivery systems.
@en
type
label
Novel central nervous system drug delivery systems.
@ast
Novel central nervous system drug delivery systems.
@en
prefLabel
Novel central nervous system drug delivery systems.
@ast
Novel central nervous system drug delivery systems.
@en
P2093
P2860
P356
P1476
Novel central nervous system drug delivery systems.
@en
P2093
Changiz Taghibiglou
Jocelyn Stockwell
Nabiha Abdi
Oshin Maheshwari
Xiaofan Lu
P2860
P304
P356
10.1111/CBDD.12268
P577
2014-03-14T00:00:00Z